IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome

Conditions:   Myelodysplastic Syndromes;   Leukemia Acute Myeloid Intervention:   Drug: AG-221 Sponsor:   Groupe Francophone des Myelodysplasies Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials